Zydus Cadila gets final approval from USFDA to market generic tension headache tablets

The company has received final approval from the United States Food
and Drug Administration (USFDA) to market Butalbital, Acetaminophen
and Caffeine tablets in strengths of 50mg/325mg/40 mg, Zydus Cadila
said in a statement. The drug will be manufactured at Nesher Pharma's
manufacturing facility at St. Louis in the US, it added.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-final-approval-from-usfda-to-market-generic-tension-headache-tablets/articleshow/77035884.cms